Print

Obesity Raises Death Risk in Pancreatic Cancer, Dana-Farber Cancer Institute Study  
10/22/2013 6:12:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

New results from a prospective study published in the Journal of Clinical Oncology show that patients with a body mass index (BMI) in the obese range live on average two to three months less after a pancreatic cancer diagnosis, compared with healthy weight patients, even after adjusting for factors that are known to predict survival for patients with this disease, such as age and disease stage. This association was statistically strongest for people who were overweight two decades before their diagnosis.

Hey, check out all the research scientist jobs. Post your resume today!

//-->